Journal Information
Visits
215
Review article
Full text access
Uncorrected Proof. Available online 17 February 2025
Lack of association between the TMPRSS6 gene polymorphism (rs855791) and anemia: a comprehensive meta-analysis
Visits
215
Jethendra Kumar Muruganantham, Ramakrishnan Veerabathiran
Corresponding author
rkgenes@gmail.com

Corresponding author at: Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, 603103 Tamilnadu, India.
Human Cytogenetics and Genomics Laboratory, Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Tamilnadu 603103, India
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (4)
Show moreShow less
Additional material (1)
Abstract
Background

Anemia affects around 1.6 billion people worldwide and presents a significant challenge for healthcare providers. Despite the hemoglobin concentration being commonly used for diagnosis, identifying underlying causes remains challenging, particularly in vulnerable groups like children under five and pregnant women. Genetic factors, notably variations in the TMPRSS6 gene, are implicated in iron deficiency anemia, yet the precise relationship with anemia remains unclear.

Methods

A thorough literature search was conducted across databases, including Embase, Google Scholar, and PubMed, focusing on studies investigating TMPRSS6 gene polymorphisms and anemia. Thirteen eligible studies, comprising 2082 cases and 2684 controls, underwent meta-analysis using Review Manager 5.4 software. Various genetic models were assessed, including allelic, homozygous, heterozygous, dominant, and recessive, with no significant relationship found between the TMPRSS6 rs855791 polymorphism and anemia.

Conclusion

This meta-analysis provides robust evidence suggesting no significant association between the TMPRSS6 rs855791gene polymorphism and anemia. These findings underscore the complexity of genetic factors contributing to anemia and emphasize the importance of the further investigation to unravel the mechanisms underlying this relationship for improved diagnostic and therapeutic approaches.

Keywords:
Genetics
Anemia
Polymorphisms
TMPRSS6 gene
Iron deficiency
Full Text
Introduction

About 1.6 billion individuals worldwide are affected by anemia, a common hematological disorder encountered by general practitioners and hospital doctors.1 Using the patient's hemoglobin (Hb) concentration to diagnose anemia is common practice, yet this information alone may not pinpoint the underlying disease responsible for the anemia.2 Children under five years old and pregnant and non-pregnant women aged 15–49 are considered the most vulnerable groups, with global prevalence estimates indicating rates of 47 %, 42 %, and 30 % for anemia, respectively.3 Anemia is not a singular disease but a broad spectrum of pathological disorders. It is defined functionally and quantitatively as a state where there are insufficient erythrocytes (oxygen-carrying blood cells) in the bloodstream to meet metabolic demands. In clinical practice, the identification of anemia relies on measures such as Hb levels, hematocrit, or red blood cell count that falls below the expected norms adjusted for age and sex.4 Several factors influence Hb levels, including smoking, residing at high altitudes, and dietary habits. Children in high-altitude regions can refer to normalized Hb value curves for accurate assessment. Moreover, individual genetic differences, as revealed by genome-wide association studies, contribute to variations in erythrocyte indices.5 Iron deficiency or anemia in young children can lead to poor growth and failure to thrive, affecting their neurocognitive and behavioral development.6 Historically, iron deficiency anemia (IDA) has been associated with environmental factors such as illness and nutrition. Recent studies suggest that genetic factors play a significant role in the development of IDA. Approximately 20–30 % of the variations in iron concentration may be due to genetic factors.7 Common single nucleotide polymorphisms (SNPs) that have been replicated and shown to influence inter-individual variance in blood Hb levels are associated with various biological processes. These processes include Hb production, erythropoiesis (the production of red blood cells), and iron metabolism.8 Genetic alterations in the gene coding for transferrin (TF), transmembrane serine protease 6 (TMPRSS6), and solute carrier family 40 member 1 (SLC40A1) are the primary sources of genetic diversity leading to iron deficiency. Among these genes, mutations in the TMPRSS6 gene are frequently linked to reduced iron levels and hematological parameters, such as erythrocyte volumes and Hb concentrations.9

The TMPRSS6 gene, predominantly expressed in the liver, plays a crucial role in regulating iron homeostasis by negatively modulating the synthesis of hepcidin, the master hormone governing iron levels in the body.10 Matriptase-2 (MT-2) hinders the expression of hepcidin and is encoded by the TMPRSS6 gene.11 The MT-2 protein domain borders align precisely with the intron/exon junctions across all species in this gene located on chromosome 22, consisting of 18 exons and 17 intervening introns.12 Several TMPRSS6 SNPs were implicated as indicators of low blood indices, such as rs855791 and rs4820268.13 The current meta-analysis seeks to elucidate the relationship between the TMPRSS6 rs855791 variant and the occurrence of IDA.

MethodologyLiterature search

PubMed, Google Scholar, and Embase were used to search for anemia-related articles with TMPRSS6 gene, polymorphism, SNPs, and genetic variations as search criteria. The meta-analysis assessed relevant references with predetermined inclusion/exclusion criteria.

Inclusion and exclusion criteria

As a prerequisite to conducting an accurate meta-analysis, specific criteria were established to determine the suitability of relevant studies. The studies needed a case-control or similar design, focusing on the correlation between the TMPRSS6 gene and anemia. The studies also had to deliver genotype and allelic frequency data, consistent 95 % confidence intervals (95 % CIs), and p-values for assessing the odds ratio (OR). The Newcastle-Ottawa Scale (NOS) was used to interpret the meta-analysis results. Any research that failed to meet these criteria or had insufficient data was disregarded.

Data extraction

Using the criteria, the researchers systematically gathered relevant papers and conducted data extraction in a standardized manner. A comprehensive examination of available publications was performed to retrieve details on allelic frequencies and genotypes for both case and control participants. In cases where genotypic data was insufficiently provided, it was derived from existing data, such as allelic frequencies. Studies that could not obtain meaningful data from both case and control groups were excluded. The extracted data from each study encompasses the Pubmed ID, study design, publication year, first author name, sample size, ethnicity, Hardy-Weinberg equilibrium (HWE) score, language, and other pertinent information. Figure 1 depicts a Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart that describes how papers were selected and screened for meta-analysis.

Figure 1.

Study selection of the TMPRSS6 rs855791 gene polymorphism and anemia.

(0.32MB).
Risk bias

The Cochrane Rob Tool 2 was utilized to thoroughly measure the methodological quality of the chosen studies, as depicted in Figure 2(a). In this representation, each study is described in a row and each column corresponds to a specific type of bias. The color assigned to each survey indicates the reviewer's evaluation of the bias risk associated with that particular type of analysis. Studies with a low bias risk are represented in green, while those with a high risk of bias are shown in red. Yellow indicates an unclear risk of bias. Overall, the findings suggest a significantly low bias risk for the selected studies, indicating that the research was conducted, executed, and documented to substantially minimize or eliminate potential bias or error.

Figure 2.

(a): Risk of bias summary and graph for investigating the TMPRSS6 rs855791 gene polymorphism (b): Sensitivity analysis of rs855791 for both cases and controls.

(0.47MB).
Statistical analysis

The statistics we analyzed using Review Manager 5.4 software with a statistical consequence threshold of p-value <0.05 for each genetic variation. The chi-square-based Q statistic test was used to examine heterogeneity assumptions across previous research, measured by the I2 metric value. In earlier studies, the random-effect model was used to evaluate the odds ratio and 95 % CI, creating a forest plot for ease of evaluation. Additionally, we used a funnel plot to scrutinize potential publication bias within the meta-analysis. The chromosomal interactions with the SNPs are represented by a Circos plot to visualize the complete data using the 3D SNP tool in Figure 3.

Figure 3.

Circos plot showing chromosomal interactions involving the rs855791 single nucleotide polymorphism.

(0.55MB).
ResultsStudy characteristics

Figure 1 thoroughly illustrates the study selection and assessment process, which adheres to rigorous inclusion and exclusion criteria. At the outset, 795 publications were comprehensively gathered and meticulously evaluated to ensure their suitability. The inclusion of thirteen studies in this meta-analysis was based on careful assessment using the HWE score and NOS scale to ensure data accuracy and reliability. The characteristics of the studies, including their NOS score, are presented, and detailed information concerning genotype distribution, allelic frequency, and HWE/chi-square values for the chosen polymorphisms are provided (Table S1).

Association between the TMPRSS6 variant with anemia

Random effects were used because the I2 ≥50 % in the allelic model (I2 = 79 %; OR = 0.81; 95 % CI: 0.64–1.02; p-value = 0.08), in the homozygous model (I2 = 77 %; OR = 1.62; 95 % CI: 0.98–2.68; p-value = 0.06), in the heterozygous model (I2 = 57 %; OR = 0.87; 95 % CI: 0.63–1.18; p-value = 0.36), in the dominant model (I2 = 72 %; OR = 1.34; 95 % CI: 0.95–1.90; p-value = 0.10), and in the recessive model (I2 = 72 %; OR = 1.32; 95 % CI: 0.92–1.90; p-value = 0.14). Overall, none of the five genetic models demonstrated any significant associations. All the data are shown using forest plots. To ascertain the sensitivity of the TMPRSS6 rs855791 polymorphism, a comprehensive analysis was carried out, encompassing Begg's funnel plot and Egger's test. Figures 4 and S1 reveal no publication bias for the five genetic models in the data.

Figure 4.

Forest plot showing the association between the TMPRSS6 rs855791 gene polymorphism and anemia in the genetic model.

(0.84MB).
An examination of sensitivity analysis

A sensitivity analysis for the TMPRSS6 gene variation (rs855791) was performed, and the results in Figure 2(b) were similar. We, therefore, conclude that our findings are statistically significant.

Discussion

Genetic variations in DNA, particularly changes in SNPs, can influence how specific amino acid conversions in a protein affect the functions and activity of a gene.14 Genetic variations in the TMPRSS6 gene impact hematologic parameters and serum iron levels. Additionally, it was discovered that SNPs of the TMPRSS6 gene were connected to quantitative changes in hematologic markers. Whether the relationship between the TMPRSS6 gene variations and erythropoiesis relies on iron is unknown.15 A study involving female university students in northern Saudi Arabia showed that the TMPRSS6 polymorphism rs855791 significantly correlated with reduced iron levels. At the same time, rs2111833 did not show such a correlation.16 The study provides relevant data concerning the genotype distribution of SNPs in the TF, TMPRSS6, and HFE genes, along with their potential association with the iron status and blood iron levels of pregnant Filipino women.17 Data from Taiwan indicated that reproductive-age women diagnosed with IDA exhibited a reduced frequency of the TMPRSS6 rs855791 CC genotype compared to women without the condition.18 It is essential to acknowledge that IDA is a multifactorial condition influenced by various factors such as nutrition, socioeconomic status, gender, and age. These non-genetic factors are often more prevalent and could overshadow the genetic contributions, making it difficult to detect a direct correlation between TMPRSS6 polymorphisms and anemia.30

Additionally, this study did not differentiate between IDA and iron refractory-iron deficiency anemia (IRIDA), a specific subtype of anemia that is more likely to be influenced by genetic factors such as TMPRSS6 polymorphisms.31 IRIDA, characterized by a poor response to oral iron therapy, has been directly linked to mutations in the TMPRSS6 gene, with rs855791 being one of the polymorphisms of interest. Studies have shown that individuals with IRIDA are more likely to carry specific TMPRSS6 variants, which disrupt iron regulation and lead to persistent anemia.32

This meta-analysis, which consisted of 2082 cases and 2684 controls, aimed to establish a correlation between anemia and TMPRSS6 gene polymorphisms with a specific SNP. We tabulated the results using overall OR, a 95 % CI, and p-value. This study unequivocally found no evidence of a relationship between anemia and TMPRSS6 (rs855791) in all genetic models. Therefore, our findings strongly suggest no potential link between the TMPRSS6 rs855791 gene polymorphism and anemia. This study provides important insights into the lack of association between anemia and variations in the TMPRSS6 gene. The results of this study differ from previous studies due to a larger sample size, diverse population coverage, and more rigorous methodologies, including comprehensive genetic model assessments and publication bias evaluations. These factors may have revealed a lack of association that smaller, less robust studies did not detect. Further research is needed to understand how variations in the TMPRSS6 gene are connected to anemia. Additional studies with more diverse populations are required to explore other TMPRSS6 polymorphisms, gene-gene interactions, and iron metabolism pathways. Longitudinal studies and functional assays could also provide deeper insights into the gene's role in anemia. Delving deeper could uncover vital information for better diagnostics and treatments. This study is a significant milestone in improving healthcare for individuals with IDA, as it enhances our understanding of this relationship.

Conclusion

This comprehensive meta-analysis examined the association between the TMPRSS6 gene polymorphism (rs855791) and anemia, incorporating data from 13 studies comprising over 4700 participants. Contrary to previous hypotheses, our findings revealed no significant correlation between the TMPRSS6 rs855791 gene variation and anemia across various genetic models. These results suggest that the TMPRSS6 rs855791 polymorphism may not play a substantial part in predisposing individuals to anemia. However, given the multifactorial nature of anemia and the complexity of genetic influences, further investigation is warranted to elucidate the precise mechanisms underlying anemia development and identify additional genetic factors. Such insights are crucial for refining diagnostic methods and developing targeted therapeutic interventions, ultimately improving clinical management and outcomes for individuals affected by anemia.

Author contributions

JM wrote the contents, edited the figures and tables of this manuscript. RV designed the study, edited the contents of this manuscript, and approved the manuscript for submission. All authors read and approved the final manuscript.

Uncited references

19,20,21,22,23,24,25,26,27,28,29

Acknowledgment

Thanks to the Chettinad Academy of Research and Education for their continuous support and encouragement.

References
[1]
E. McLean, M. Cogswell, I. Egli, D. Wojdyla, B. de Benoist.
Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005.
Public Health Nutr, 12 (2009), pp. 444-454
[2]
D.A. Newhall, R. Oliver, S. Lugthart.
Anaemia: a disease or symptom.
Neth J Med, 78 (2020), pp. 104-110
[3]
C.M. Chaparro, P.S. Suchdev.
Anemia epidemiology, pathophysiology, and etiology in low- and middle-income countries.
Ann N Y Acad Sci, 1450 (2019), pp. 15-31
[4]
P.G. Gallagher.
Anemia in the pediatric patient.
Blood, 140 (2022), pp. 571-593
[5]
T. Timmer, M.W.T. Tanck, In 't Veld EMJ Huis, et al.
Associations between single nucleotide polymorphisms and erythrocyte parameters in humans: a systematic literature review.
Mutat Res Rev Mutat Res, 779 (2019), pp. 58-67
[6]
E. Zhukovskaya, A. Karelin, A. Rumyantsev.
Neurocognitive dysfunctions in iron deficiency patients [Internet].
Iron Deficiency Anemia, IntechOpen, (2019), http://dx.doi.org/10.5772/intechopen.82620
[7]
T. Tanaka, C.N. Roy, W. Yao, et al.
A genome-wide association analysis of serum iron concentrations.
[8]
V.J. Timoteo, K.M. Chiang, H.C. Yang, W.H. Pan.
Common and ethnic-specific genetic determinants of hemoglobin concentration between Taiwanese Han Chinese and European Whites: findings from comparative two-stage genome-wide association studies.
[9]
L.H. Al-Jamea, A. Woodman, N.M. Heiba, et al.
Genetic analysis of TMPRSS6 gene in Saudi female patients with iron deficiency anemia.
Hematol Oncol Stem Cell Ther, 14 (2021), pp. 41-50
[10]
C.Y. Wang, D. Meynard, H.Y. Lin.
The role of TMPRSS6/matriptase-2 in iron regulation and anemia.
Front Pharmacol, 5 (2014), pp. 114
[11]
W.N. Gichohi-Wainaina, T. Tanaka, G.W. Towers, et al.
Associations between common variants in iron-related genes with haematological traits in populations of African ancestry.
[12]
A.J. Ramsay, J.D. Hooper, A.R. Folgueras, G. Velasco, C. López-Otín.
Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis.
Haematologica, 94 (2009), pp. 840-849
[13]
J.C. Chambers, W. Zhang, Y. Li, et al.
Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels.
Nat Genet, 41 (2009), pp. 1170-1172
[14]
C.M. Yates, M.J. Sternberg.
The effects of non-synonymous single nucleotide polymorphisms (nsSNPs) on protein-protein interactions.
J Mol Biol, 425 (2013), pp. 3949-3963
[15]
E. Poggiali, F. Andreozzi, I. Nava, D. Consonni, G. Graziadei, M.D. Cappellini.
The role of TMPRSS6 polymorphisms in iron deficiency anemia partially responsive to oral iron treatment.
Am J Hematol, 90 (2015), pp. 306-309
[16]
O. Al-Amer, Y. Hawasawi, A.A.A. Oyouni, et al.
Study the association of transmembrane serine protease 6 gene polymorphisms with iron deficiency status in Saudi Arabia.
[17]
V.J. Timoteo, L.M. Dalmacio, J.S. Nacis, J.M. Marcos, M.P. Rodriguez, M.V. Capanzana.
Blood iron concentration and status in pregnant Filipino women with single nucleotide polymorphisms in HFE, TMPRSS6, and TF.
Philipp J Sci, 147 (2018), pp. 99-112
[18]
S.N. Pei, M.C. Ma, H.L. You, et al.
TMPRSS6 rs855791 polymorphism influences the susceptibility to iron deficiency anemia in women at reproductive age.
Int J Med Sci, 11 (2014), pp. 614-619
[19]
A.M. Nalado, C. Dickens, T. Dix-Peek, et al.
TMPRSS6 rs855791 polymorphism and susceptibility to iron deficiency anaemia in non-dialysis chronic kidney disease patients in South Africa.
Int J Mol Epidemiol Genet, 10 (2019), pp. 1-9
[20]
F. Keshavarzi, B. Nikkhoo.
Association of rs855791TMPRSS6 polymorphism with iron deficiency anemia.
Sci J Iran Blood Transfus Organ, 18 (2021), pp. 205-214
[21]
B. Batar, I. Bavunoglu, Y. Hacioglu, et al.
The role of TMPRSS6 gene variants in iron-related hematological parameters in Turkish patients with iron deficiency anemia.
[22]
H.L. Abeywickrama, M.S. Rabindrakumar, L.S. Pathira Kankanamge, T. Thoradeniya, G.H Galhena.
TMPRSS6 rs855791 polymorphism is associated with iron deficiency in a cohort of Sri Lankan pregnant women.
Egypt J Med Human Genetics, 23 (2022), pp. 164
[23]
H.M. Hamed, E.E. Bostany, A.A. Motawie, et al.
The association of TMPRSS6 gene polymorphism with iron status in Egyptian children (a pilot study).
BMC Pediatr, 24 (2024), pp. 105
[24]
K. Urbaszek, N. Drabińska, A. Szaflarska-Popławska, E. Jarocka-Cyrta.
TMPRSS6 rs855791 Polymorphism status in children with celiac disease and anemia.
Nutrients, 13 (2021), pp. 2782
[25]
L. De Falco, R. Tortora, N. Imperatore, et al.
The role of TMPRSS6 and HFE variants in iron deficiency anemia in celiac disease.
Am J Hematol, 93 (2018), pp. 383-393
[26]
N.M. Lone, S.H.S. Shah, M. Farooq, M. Arif, S. Younis, S. Riaz.
Role of TMPRSS6 rs855791 (T > C) polymorphism in reproductive age women with iron deficiency anemia from Lahore, Pakistan.
Saudi J Biol Sci, 28 (2021), pp. 748-753
[27]
N.M. Silva, M.P. Lopes, R.M. Schincaglia, A.S.G. Coelho, C. Cominetti, M.C.C.M. Hadler.
Anaemia and iron deficiency associate with polymorphism TMPRSS6 rs855791 in Brazilian children attending daycare centres.
Br J Nutr, 131 (2024), pp. 193-201
[28]
P. An, Q. Wu, H. Wang, et al.
TMPRSS6, but not TF, TFR2 or BMP2 variants are associated with increased risk of iron-deficiency anemia.
Hum Mol Genet, 21 (2012), pp. 2124-2131
[29]
T. Suksangpleng, W. Glomglao, V. Viprakasit.
Common single nucleotide polymorphism of TMPRSS6, an iron regulation gene, associated with variable red blood cell indices in deletional α-globin genotypes.
Genes (Basel), 13 (2022), pp. 1502
[30]
M.W. Jallow, C. Cerami, T.G. Clark, A.M. Prentice, S. Campino.
Differences in the frequency of genetic variants associated with iron imbalance among global populations.
[31]
P. Bhatia, A. Singh, A. Hegde, R. Jain, D. Bansal.
Systematic evaluation of paediatric cohort with iron refractory iron deficiency anaemia (IRIDA) phenotype reveals multiple TMPRSS6 gene variations.
Br J Haematol, 177 (2017), pp. 311-318
[32]
M.D. Cappellini, K.M. Musallam, A.T. Taher.
Iron deficiency anaemia revisited.
J Intern Med, 287 (2020), pp. 153-170
Copyright © 2025. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular
Download PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Article options
Tools
Supplemental materials